eQCM® software Selected by Ricerca to Optimize Compliance and Quality Business Process Automation
Quebec City, July 30, 2008 – Amadeus, a division of Xybion, a company specialized in business solutions and professional services in corporate performance, quality and compliance management today announced that Ricerca Biosciences, LLC, a CRO that delivers robust preclinical contract drug discovery and development services to US biotechnology and pharmaceutical companies, has selected Amadeus’ eQCM® software platform to automate and manage its quality and compliance management program.
Compliant with FDA regulations including GLP and cGMP and meeting AALAC and IACUC requirements, Ricerca needed to meet the ever changing regulatory landscape by efficiently automating its data-driven workflow and critical business processes.
With eQCM®, Ricerca now has a single and robust solution that enables it to electronically create, manage and securely store all content, records, dashboards and advanced reports. eQCM® software will enable Ricerca to handle among others nonconformance, Corrective Action and Preventive Action (CAPA) as well as internal and external audits, customer complaints and document management.
“Amadeus’ software emerged from our selection process as the optimal candidate for meeting our numerous needs’’ said Stephen Rogenthien, Manager of GLP Operations for Ricerca. “In order to support our commitment to high levels of quality and compliance for our clients, it was fundamental for Ricerca to select and purchase a software package that allowed us to meet that commitment’’ he said.
“Building upon renowned strengths, like usability, flexibility, intuitiveness and reliability and extending those characteristics to new functionalities and improvements as our In-Control Process Statistics page or powerful systems tasks, to name a few capabilities, our quality and compliance technology platform significantly increases operational efficiency and performance ’’ said Pierre-François Isabel, Vice-President of Amadeus, a division of Xybion. “We continue to be recognized as a first-class player,’’ he said.
About Ricerca
Ricerca is the only North American CRO to offer the unique IP-INDSM concept to pharmaceutical and biotechnology companies. The site encompasses all discovery and development services required to bring a target or drug candidate to a complete IND submission. The ability to perform both chemistry (medicinal chemistry, process chemistry, cGMP API kilo-lab and pilot plant production, complete analytical) and biology (DMPK, ADME, full toxicology, safety pharmacology, animal efficacy models, bioanalytical) as well as report writing and regulatory services at one site makes Ricerca the provider of choice for virtual, small, and medium-sized pharmaceutical companies seeking a successful IND submission.
About Amadeus
Amadeus, a division of Xybion, is a leading provider of Enterprise Quality and Compliance Management software solutions. For over 14 years, customers in the Life Sciences, Manufacturing, Financial Services and other industries have automated their compliance and quality processes using Amadeus software platforms. Its flagship product, eQCM®, offers an integrated and very cost effective solution for enterprise governance, risk management, quality and compliance management. Amadeus’s solutions have been implemented in more than 100 companies in North America and Europe. (www.amadeussolutions.com)
- 30 -
For further information:
Isabelle Rivoal
Communications Director
Amadeus, a division of Xybion
Phone: +1 (418) 525-0606, ext. 2231
E-mail: isabelle.rivoal@amadeussolutions.com
